References
- Nomdedéu J, Hoyos M, Carricondo M, et al. Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM group. Leuk Res 2012;36:990–997.
- Zhou L, Zhu YY, Zhang XD, et al. Risk effects of GST gene polymorphisms in patients with acute myeloid leukemia: a prospective study. Asian Pac J Cancer Prev 2013;14:3861–3864.
- Wang H, Wang J, Zhao L, et al. Methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia-evidence from an updated meta-analysis including 35 studies. BMC Med Genet 2012;13:77.
- Morgan GJ, Smith MT. Metabolic enzyme polymorphisms and susceptibility to acute leukemia in adults. Am J Pharmacogenomics 2002;2:79–92.
- Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114:937–951.
- Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008;22: 14–22.
- A ZC, Yang Y, Zhang SZ, et al. Single nucleotide polymorphism C677T in the methylenetetrahydrofolate reductase gene might be a genetic risk factor for infertility for Chinese men with azoospermia or severe oligozoospermia. Asian J Androl 2007;9:57–62.
- Wu J, Li Y, Ma H, et al. Association between single nucleotide polymorphisms of MTHFR gene and susceptibility of psoriasis. Int J Genet 2007;30:173–177.
- Skibola CF, Smith MT, Kane E, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. PNAS 1999;96:12810–12815.
- Trifa AP, Cucuianu A, Popp RA, et al. Analysis of the MTHFR (methylenetetrahydrofolate reductase) 677 C> T and 1298 A> C polymorphisms in BCR–ABL-negative myeloproliferative neoplasms. Int J Lab Hematol 2013;35:e9–e12.
- Vahid P, Farnaz R, Zaker F, et al. Methylenetetrahydrofolate reductase gene polymorphisms and risk of myeloid leukemia. Lab Med 2010;41:490–494.
- Barbosa CG, Souza CL, Neto JP, et al. Methylenetetrahydrofolate reductase polymorphisms in myeloid leukemia patients from Northeastern Brazil. Genet Mol Biol 2008;31:29–32.
- Amorim MR, Zanrosso CW, Magalhães IQ, et al. MTHFR 677C→T and 1298A→C polymorphisms in children with Down syndrome and acute myeloid leukemia in Brazil. Pediatr Hematol Oncol 2008;25: 744–750.
- Da Costa Ramos FJ, Cartaxo Muniz MT, Silva VC, et al. Association between the MTHFR A1298C polymorphism and increased risk of acute myeloid leukemia in Brazilian children. Leuk Lymphoma 2006;47:2070–2075.
- Qin YT, Zhang Y, Wu F, et al. Association between MTHFR polymorphisms and acute myeloid leukemia risk: a meta-analysis. PLoS One 2014;9:e88823.